Arterial calcification in diabetes mellitus

Preclinical models and translational implications

John N. Stabley, Dwight A. Towler

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Diabetes mellitus increasingly afflicts our aging and dysmetabolic population. Type 2 diabetes mellitus and the antecedent metabolic syndrome represent the vast majority of the disease burden - increasingly prevalent in children and older adults. However, type 1 diabetes mellitus is also advancing in preadolescent children. As such, a crushing wave of cardiometabolic disease burden now faces our society. Arteriosclerotic calcification is increased in metabolic syndrome, type 2 diabetes mellitus, and type 1 diabetes mellitus - impairing conduit vessel compliance and function, thereby increasing the risk for dementia, stroke, heart attack, limb ischemia, renal insufficiency, and lower extremity amputation. Preclinical models of these dysmetabolic settings have provided insights into the pathobiology of arterial calcification. Osteochondrogenic morphogens in the BMP-Wnt signaling relay and transcriptional regulatory programs driven by Msx and Runx gene families are entrained to innate immune responses - responses activated by the dysmetabolic state - to direct arterial matrix deposition and mineralization. Recent studies implicate the endothelial-mesenchymal transition in contributing to the phenotypic drift of mineralizing vascular progenitors. In this brief overview, we discuss preclinical disease models that provide mechanistic insights - and point to challenges and opportunities to translate these insights into new therapeutic strategies for our patients afflicted with diabetes mellitus and its arteriosclerotic complications.

Original languageEnglish (US)
Pages (from-to)205-217
Number of pages13
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume37
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Diabetes Mellitus
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Amputation
Innate Immunity
Compliance
Renal Insufficiency
Blood Vessels
Dementia
Lower Extremity
Ischemia
Extremities
Stroke
Myocardial Infarction
Population
Genes
Therapeutics

Keywords

  • amputation
  • arteriosclerosis
  • dementia
  • diabetes mellitus
  • vascular calcification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Arterial calcification in diabetes mellitus : Preclinical models and translational implications. / Stabley, John N.; Towler, Dwight A.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 37, No. 2, 01.02.2017, p. 205-217.

Research output: Contribution to journalReview article

@article{bcdc8f3bdafa427696121fbea9f423ef,
title = "Arterial calcification in diabetes mellitus: Preclinical models and translational implications",
abstract = "Diabetes mellitus increasingly afflicts our aging and dysmetabolic population. Type 2 diabetes mellitus and the antecedent metabolic syndrome represent the vast majority of the disease burden - increasingly prevalent in children and older adults. However, type 1 diabetes mellitus is also advancing in preadolescent children. As such, a crushing wave of cardiometabolic disease burden now faces our society. Arteriosclerotic calcification is increased in metabolic syndrome, type 2 diabetes mellitus, and type 1 diabetes mellitus - impairing conduit vessel compliance and function, thereby increasing the risk for dementia, stroke, heart attack, limb ischemia, renal insufficiency, and lower extremity amputation. Preclinical models of these dysmetabolic settings have provided insights into the pathobiology of arterial calcification. Osteochondrogenic morphogens in the BMP-Wnt signaling relay and transcriptional regulatory programs driven by Msx and Runx gene families are entrained to innate immune responses - responses activated by the dysmetabolic state - to direct arterial matrix deposition and mineralization. Recent studies implicate the endothelial-mesenchymal transition in contributing to the phenotypic drift of mineralizing vascular progenitors. In this brief overview, we discuss preclinical disease models that provide mechanistic insights - and point to challenges and opportunities to translate these insights into new therapeutic strategies for our patients afflicted with diabetes mellitus and its arteriosclerotic complications.",
keywords = "amputation, arteriosclerosis, dementia, diabetes mellitus, vascular calcification",
author = "Stabley, {John N.} and Towler, {Dwight A.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1161/ATVBAHA.116.306258",
language = "English (US)",
volume = "37",
pages = "205--217",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Arterial calcification in diabetes mellitus

T2 - Preclinical models and translational implications

AU - Stabley, John N.

AU - Towler, Dwight A.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Diabetes mellitus increasingly afflicts our aging and dysmetabolic population. Type 2 diabetes mellitus and the antecedent metabolic syndrome represent the vast majority of the disease burden - increasingly prevalent in children and older adults. However, type 1 diabetes mellitus is also advancing in preadolescent children. As such, a crushing wave of cardiometabolic disease burden now faces our society. Arteriosclerotic calcification is increased in metabolic syndrome, type 2 diabetes mellitus, and type 1 diabetes mellitus - impairing conduit vessel compliance and function, thereby increasing the risk for dementia, stroke, heart attack, limb ischemia, renal insufficiency, and lower extremity amputation. Preclinical models of these dysmetabolic settings have provided insights into the pathobiology of arterial calcification. Osteochondrogenic morphogens in the BMP-Wnt signaling relay and transcriptional regulatory programs driven by Msx and Runx gene families are entrained to innate immune responses - responses activated by the dysmetabolic state - to direct arterial matrix deposition and mineralization. Recent studies implicate the endothelial-mesenchymal transition in contributing to the phenotypic drift of mineralizing vascular progenitors. In this brief overview, we discuss preclinical disease models that provide mechanistic insights - and point to challenges and opportunities to translate these insights into new therapeutic strategies for our patients afflicted with diabetes mellitus and its arteriosclerotic complications.

AB - Diabetes mellitus increasingly afflicts our aging and dysmetabolic population. Type 2 diabetes mellitus and the antecedent metabolic syndrome represent the vast majority of the disease burden - increasingly prevalent in children and older adults. However, type 1 diabetes mellitus is also advancing in preadolescent children. As such, a crushing wave of cardiometabolic disease burden now faces our society. Arteriosclerotic calcification is increased in metabolic syndrome, type 2 diabetes mellitus, and type 1 diabetes mellitus - impairing conduit vessel compliance and function, thereby increasing the risk for dementia, stroke, heart attack, limb ischemia, renal insufficiency, and lower extremity amputation. Preclinical models of these dysmetabolic settings have provided insights into the pathobiology of arterial calcification. Osteochondrogenic morphogens in the BMP-Wnt signaling relay and transcriptional regulatory programs driven by Msx and Runx gene families are entrained to innate immune responses - responses activated by the dysmetabolic state - to direct arterial matrix deposition and mineralization. Recent studies implicate the endothelial-mesenchymal transition in contributing to the phenotypic drift of mineralizing vascular progenitors. In this brief overview, we discuss preclinical disease models that provide mechanistic insights - and point to challenges and opportunities to translate these insights into new therapeutic strategies for our patients afflicted with diabetes mellitus and its arteriosclerotic complications.

KW - amputation

KW - arteriosclerosis

KW - dementia

KW - diabetes mellitus

KW - vascular calcification

UR - http://www.scopus.com/inward/record.url?scp=85007201684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007201684&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.116.306258

DO - 10.1161/ATVBAHA.116.306258

M3 - Review article

VL - 37

SP - 205

EP - 217

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 2

ER -